Precision Biosciences gets grant for engineered meganucleases for modifying human mitochondrial dna
Pharmaceutical Technology
APRIL 30, 2024
Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.
Let's personalize your content